Interleukin-15-transpresenting Wilms' tumor protein 1-targeting autologous dendritic cell vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-15-transpresenting Wilms' tumor protein 1-targeting autologous dendritic cell vaccine, covering 2025-04-25 to 2025-04-25. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients [Phase 1, Phase 2]